Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Expands Screener Software Agreement with Roche

NEW YORK, Dec. 19 (GenomeWeb News) - Genedata has extended an agreement with Roche to deploy its Screener software at all of Roche's high-throughput screening facilities in North America and Europe, Genedata said today.

 

Under the terms of the original agreement, Roche used Genedata's software at its Basel, Switzerland-facility. The agreement expands the collaboration to include more facilities over several years.

 

Roche Scientists use Screener to estimate the biological potency of thousands of compounds, Genedata said.

 

The software has been already deployed to four sites in "a very short time period," Genedata said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.